Source comparison
CJC-1295 Dosage Muscle Growth 2026: Comparison Table
Conservative Hypertrophy 100–150mcg 3x weekly 300–450mcg Moderate IGF-1 elevation, minimal side effect risk Low. Well below saturation threshold Best for first-time researchers or those prioritizing safety over maximal response Standard Hypertrophy 200–300mcg
This comparison does not assign a generated winner or score.
- Conservative Hypertrophy
- 100–150mcg
- 3x weekly
- 300–450mcg
- Moderate IGF-1 elevation, minimal side effect risk
- Low. Well below saturation threshold
- Best for first-time researchers or those prioritizing safety over maximal response
- Standard Hypertrophy
- 200–300mcg
- 2–3x weekly
- 400–900mcg
- Maximal anabolic signaling without receptor saturation
- Moderate at 3x weekly dosing
- Most widely validated protocol in hypertrophy literature. Balances efficacy and tolerability
- Aggressive Hypertrophy
- 400–500mcg
- 2x weekly
- 800–1000mcg
- Near-maximal receptor occupancy, highest IGF-1 response
- High. Approaching saturation ceiling
- Diminishing returns above 300mcg per dose; only justified in advanced protocols with cycling
- Recomposition
- 150–200mcg
- 450–600mcg
- Lipolysis + lean mass retention
- Low to moderate
- Lower per-dose amount preserves GH's fat-mobilizing effect without overshooting anabolic threshold
- Maintenance/Bridge
- 100–200mcg
- 1–2x weekly
- 100–400mcg
- Sustain baseline GH elevation between higher-dose cycles
- Very low
- Used during off-cycle periods to maintain elevated IGF-1 without chronic receptor exposure